Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

2543 - Kynurenine 3-monooxygenase as a potential biomarker for colorectal cancer

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Topics

Translational Research

Tumour Site

Colon and Rectal Cancer

Presenters

Chun-Yu Liu

Citation

Annals of Oncology (2018) 29 (suppl_8): viii150-viii204. 10.1093/annonc/mdy281

Authors

C. Liu1, C. Lee1, J. Chen1, T. Huang1, S. Yang2, J. Jiang3, W. Chen2, K. Lee4, H. Teng1

Author affiliations

  • 1 Oncology, Taipei Veterans General Hospital, 11217 - Taipei/TW
  • 2 Surgery, Taipei Veterans General Hospital, 11217 - Taipei/TW
  • 3 Surgery, Taipei Veterans General Hospital, 112 - Taipei/TW
  • 4 Internal Medicine, Taipei Medical University Hospital, Taipei/TW

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2543

Background

Colorectal cancer (CRC) is the third most common cancer and the cause of cancer-related deaths worldwide. Due to the lack of highly sensitive and specific biomarkers, colorectal cancer often identified at the late stages in most patients when diagnosed. Identifying the potential cancer marker and understanding the mechanisms of metastasis and progression behind colorectal cancer is crucial for human CRC. Kynurenine 3-monooxygenase (KMO) is a monooxygenase participating in tryptophan metabolism. Previous studies showed that KMO related to metastasis and proliferation in hepatocellular carcinoma. However, the biological role of KMO in human CRC is still unclear.

Methods

The expression level of KMO in patients with CRC was examined using immunohistochemistry (IHC). The correlation between KMO expression and patient survival rate was analyzed using The Cancer Genome Atlas (TCGA) database. CRC cell lines were used to perform functional assays. UPF 648, a potent KMO inhibitor, and RNAi against KMO and luciferase were used for in vitro studies. Cell viability was analyzed by MTT assay. Cells motility was examined by transwell assay. Stemness properties were assessed by sphere assay and the expression of cancer stem cells markers.

Results

IHC data showed that the expression of KMO was upregulated in CRC tumor tissues compared with normal counterparts of CRC. Furthermore, higher level of KMO transcript was associated with worse overall survival in CRC patients in TCGA database. Knockdown of KMO inhibited the expression of cancer stem cells markers, including CD44 and Nanog, as well as abilities of migration and invasion of CRC cells. Furthermore, the effect of KMO activity inhibition in cell viability was cell lines specific whereas the abilities of cell migration, invasion and sphere formation in CRC cells were significantly suppressed by UPF 648 treatment.

Conclusions

Our data suggests that KMO may serve as a potential biomarker and play tumor-promoting role in CRC.

Clinical trial identification

Legal entity responsible for the study

Chun-Yu Liu.

Funding

Has not received any funding.

Editorial Acknowledgement

Disclosure

C. Liu, X. Mao: Employee of Burning Rock Biotech. All other authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.